Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

P207 NRAS Virtual Groups

View through CrossRef
Abstract Background/Aims NRAS Groups have long provided an opportunity for those with RA to meet others in a similar situation for mutual benefit. Attendees have told us how they enjoy meeting in a non-clinical environment to learn more about the condition and receive encouragement from others. When COVID-19 hit and NRAS groups were unable to meet in person and most people living with RA had to shield this intensified the feelings of isolation. NRAS responded to this need by establishing online regional groups and JoinTogether virtual groups. Methods 1. NRAS offered training and support to facilitate online group meetings to its regional groups’ leaders. Volunteers were provided with a dedicated NRAS email address, access to an Office 365 portal and Zoom account and GDPR training. NRAS colleagues attended introductory meetings to support the Group Leaders and continue to provide technical support, promotion via website and social media as well as general advice. 2. Recognising a need to reach a wider audience who were not accessing the regional groups - i.e. younger and perhaps “time poor” due to working etc. - NRAS took advantage of the move to online engagement and also initiated the exclusively online JoinTogether topic-based groups, using a Volunteer Lead model. Results Regional Groups: Almost half of the regional groups signed up to the online training. Many found that the online meetings brought very positive benefits e.g. they were able to reach a wider audience as attendees were not put off by having to travel and could still attend if they were feeling fatigued. Many reported it was easier to attract NHS rheumatology health professionals to give talks as they did not have to travel and could even join meetings from home in the evenings. Some groups in adjoining areas joined forces so they could expand their offerings. JoinTogether Groups: Volunteer Lead, with NRAS support, has now set up 5 topic-based groups, each led by two co-ordinators. Topics are: Exercise & Back to Sport; Parenting With Inflammatory Arthritis; 18-35 year olds with RA or JIA: Working with Inflammatory Arthritis and Parents with children with JIA. These groups are thriving and attracting new audiences. They are very much volunteer led and attendees play a key role in directing the development of the JoinTogether groups to suit their needs. Conclusion NRAS virtual groups have allowed those living with RA or JIA to maintain contact with a community, with shared experiences, throughout the pandemic. They have also been instrumental in attracting attendees from audiences NRAS had traditionally found harder to access. The Volunteer Lead model that has been successfully implemented for the JoinTogether groups can now be expanded to other areas, enabling NRAS to increase capacity for delivering vital services. Disclosure N. Bwalya: None. J. Brewer: None.
Oxford University Press (OUP)
Title: P207 NRAS Virtual Groups
Description:
Abstract Background/Aims NRAS Groups have long provided an opportunity for those with RA to meet others in a similar situation for mutual benefit.
Attendees have told us how they enjoy meeting in a non-clinical environment to learn more about the condition and receive encouragement from others.
When COVID-19 hit and NRAS groups were unable to meet in person and most people living with RA had to shield this intensified the feelings of isolation.
NRAS responded to this need by establishing online regional groups and JoinTogether virtual groups.
Methods 1.
NRAS offered training and support to facilitate online group meetings to its regional groups’ leaders.
Volunteers were provided with a dedicated NRAS email address, access to an Office 365 portal and Zoom account and GDPR training.
NRAS colleagues attended introductory meetings to support the Group Leaders and continue to provide technical support, promotion via website and social media as well as general advice.
2.
Recognising a need to reach a wider audience who were not accessing the regional groups - i.
e.
younger and perhaps “time poor” due to working etc.
- NRAS took advantage of the move to online engagement and also initiated the exclusively online JoinTogether topic-based groups, using a Volunteer Lead model.
Results Regional Groups: Almost half of the regional groups signed up to the online training.
Many found that the online meetings brought very positive benefits e.
g.
they were able to reach a wider audience as attendees were not put off by having to travel and could still attend if they were feeling fatigued.
Many reported it was easier to attract NHS rheumatology health professionals to give talks as they did not have to travel and could even join meetings from home in the evenings.
Some groups in adjoining areas joined forces so they could expand their offerings.
JoinTogether Groups: Volunteer Lead, with NRAS support, has now set up 5 topic-based groups, each led by two co-ordinators.
Topics are: Exercise & Back to Sport; Parenting With Inflammatory Arthritis; 18-35 year olds with RA or JIA: Working with Inflammatory Arthritis and Parents with children with JIA.
These groups are thriving and attracting new audiences.
They are very much volunteer led and attendees play a key role in directing the development of the JoinTogether groups to suit their needs.
Conclusion NRAS virtual groups have allowed those living with RA or JIA to maintain contact with a community, with shared experiences, throughout the pandemic.
They have also been instrumental in attracting attendees from audiences NRAS had traditionally found harder to access.
The Volunteer Lead model that has been successfully implemented for the JoinTogether groups can now be expanded to other areas, enabling NRAS to increase capacity for delivering vital services.
Disclosure N.
Bwalya: None.
J.
Brewer: None.

Related Results

Abstract B26: Receptor tyrosine kinase signaling mediates resistance in NRAS mutant melanoma
Abstract B26: Receptor tyrosine kinase signaling mediates resistance in NRAS mutant melanoma
Abstract Targeted therapies have revolutionized cancer care but it is clear that for most solid tumors suppression of a single target is not sufficient to prevent th...
Abstract 5076: Dissection of RAS downstream pathways in melanomagenesis
Abstract 5076: Dissection of RAS downstream pathways in melanomagenesis
Abstract Cutaneous malignant melanoma is considered one of the most deadly human cancers, based upon both its penchant for metastatic spread and its typical resistan...
Rôle de la kinase ARAF dans le mélanome cutané muté NRAS
Rôle de la kinase ARAF dans le mélanome cutané muté NRAS
Les gènes NRAS et BRAF, impliqués dans la voie de signalisation RAS/RAF/MEK/ERK, sont fréquemment mutés dans le mélanome cutané. Des inhibiteurs spécifiques de BRAF sont utilisés e...
Response and Resistance to Bromodomain Inhibition in AML Driven By Hyperactive Ras Signaling
Response and Resistance to Bromodomain Inhibition in AML Driven By Hyperactive Ras Signaling
Abstract Background: Acute myeloid leukemia (AML) is an aggressive hematologic cancer characterized by clonal proliferation of hematopoietic stem and progenitor cell...
EFEKTIFITAS PELATIHAN LABORATORIUM VIRTUAL SEBAGAI MEDIA PEMBELAJARAN BAGI GURU KIMIA
EFEKTIFITAS PELATIHAN LABORATORIUM VIRTUAL SEBAGAI MEDIA PEMBELAJARAN BAGI GURU KIMIA
EFFECTIVITY OF VIRTUAL LABORATORY TRAINING AS A LEARNING MEDIA FOR CHEMISTRY TEACHERSAchmad Lutfi, SukarminUniversitas Negeri Surabaya, Indonesia achmadlutfi@unesa.ac.idAbstractThe...
Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis
Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis
Abstract Background Upregulation of the mitogen-activated protein kinase (MAPK) cascade is common in hepatocellular carcinoma (HCC). Neuroblastoma R...
Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients
Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients
Circulating tumour DNA (ctDNA) can be used to identify gene alterations. The purpose of this study was to determine whether the detection of ctDNA, based on the identification of B...

Back to Top